Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrasers Group Regulatory News (FRAS)

Share Price Information for Frasers Group (FRAS)

Share Price is delayed by 15 minutes
Get Live Data
759.00    10.50 (1.40%)
Bid:
759.00
Ask:
761.50
Spread: 2.50 (0.329%)
Market Cap: £3.27b
FRAS Live PriceLast checked at - London Stock Exchange

Intraday Frasers Group Share Chart

Frasers Group confirms Board changes

25 Sep 2025 16:16

RNS Number : 8828A
Frasers Group PLC
25 September 2025
 

 

Date: 25 September 2025

 

 

Frasers Group confirms Board changes

 

The Board of Directors of Frasers Group plc ("the Board") announces the following director changes, reaffirming Frasers Group's ongoing commitment to driving the success of its Elevation Strategy and to strengthening its Board.

 

As announced on 29 August 2025, David Daly, Ger Wright and Helen Wright stepped down from the Board at the company's AGM on 24 September 2025. Frasers Group plc ("Frasers" or the "Group") announces the appointment of Andy Lyon as Non-Executive Director (NED) to the Board, effective 24 September 2025.

 

As announced on 15 September 2025, Frasers also announces the appointment of Jacky Wright as Non-Executive Director (NED) to the Board, effective 24 September 2025

 

Frasers Group's new Board members:

 

- Andy Lyon was previously a senior audit partner at PwC having specialised in retail and consumer markets. He led the audits of several large global retailers, both listed and privately owned, including fashion brands and department stores. During his 24 years as a partner, he had spells as senior partner for the East Midlands office, a member of the Midlands leadership team and sat on the firm's retail and consumer leadership team with responsibility for the regional practice.

 

- Jacky Wright is a globally recognised technology executive and advocate for inclusive innovation, with over three decades of experience leading digital transformation across the private and public sectors. She most recently served as Chief Technology and Platform Officer at McKinsey & Company, where she led the firm's tech strategy, AI transformation and technology modernization efforts for 40,000+ colleagues globally. She was also with Microsoft for over 10 years where she was Chief Digital Officer. Jacky currently serves on the Board of Russell Reynolds, and has held previous directorships at Exelixis and Nvent.

 

There are no other details that are required to be disclosed in respect of Rule 6.4.8 of the Listing Rules.

 

 

- ENDS -

 

FRASERS GROUP PLC

Emma Reid, Company Secretary

LEI: 213800JEGHHEAXIJDX34

T. 0344 245 9200

E. company.secretary@frasers.group

Chris Wootton, Chief Financial Officer

T. 0344 245 9200

E. financial@frasers.group

Andrew Kasoulis, Investor Relations Director

T. 07826 532191

E. Andrew.Kasoulis@frasers.group

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOASEEFIIEISESU
Date   Source Headline
1st Jun 20267:00 amRNSTotal Voting Rights
26th May 20267:00 amRNSTransaction in Own Shares
18th May 20267:00 amRNSTransaction in Own Shares
11th May 20267:00 amRNSTransaction in Own Shares
5th May 20267:00 amRNSTransaction in Own Shares
1st May 20267:00 amRNSTotal Voting Rights
29th Apr 20267:00 amRNSAcquisition of Designer Outlets (York & East Mids)
27th Apr 20267:10 amRNSPurchases of shares during open period
27th Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSTransaction in Own Shares
13th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20267:00 amRNSTotal Voting Rights
30th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 202612:45 pmRNSHolding(s) in Company
23rd Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 202611:01 amRNSHolding(s) in Company
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20265:00 pmRNSHolding(s) in Company
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20267:00 amRNSTotal Voting Rights
24th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20264:16 pmRNSHolding(s) in Company
17th Feb 20262:43 pmRNSHolding(s) in Company
17th Feb 20267:00 amRNSTransaction in Own Shares
16th Feb 20267:00 amRNSTransaction in Own Shares
12th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20265:00 pmRNSHolding(s) in Company
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20267:00 amRNSTotal Voting Rights
2nd Feb 20267:00 amRNSTransaction in Own Shares
30th Jan 20267:00 amRNSTransaction in Own Shares
29th Jan 20267:00 amRNSTransaction in Own Shares
28th Jan 20267:00 amRNSTransaction in Own Shares
27th Jan 20267:00 amRNSTransaction in Own Shares
26th Jan 20267:00 amRNSTransaction in Own Shares
23rd Jan 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.